KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Short term Debt (2023 - 2025)

Historic Short term Debt for Adaptive Biotechnologies (ADPT) over the last 3 years, with Q3 2025 value amounting to $2.4 million.

  • Adaptive Biotechnologies' Short term Debt changed N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $865000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Short term Debt of $2.4 million as of Q3 2025.
  • In the past 5 years, Adaptive Biotechnologies' Short term Debt ranged from a high of $3.2 million in Q3 2023 and a low of $865000.0 during Q4 2024
  • In the last 3 years, Adaptive Biotechnologies' Short term Debt had a median value of $2.4 million in 2025 and averaged $2.3 million.